欧盟法规
ECHA物质C&L通报上下游产品
2,3-二氯甲苯 2,3-Dichlorotoluene 32768-54-0
2,3-二氯苄醇 2,3-Dichlorobenzyl Alcohol 38594-42-22,3-二氯苯甲酸置于lithium Aluminium Tetrahydride,硫酸体系中,用 四氢呋喃,甲醇,乙酸乙酯,甲苯 作为反应溶剂,化学反应生成 2,3-二氯苄溴
参考文献:Pyrazolopyrimidine Derivatives As Pi3 Kinase Inhibitors
标题:Pyrazolopyrimidine Derivatives As Pi3 Kinase Inhibitors
摘要:具有该结构的pi3Kβ选择性化合物
专利信息
专利号:US-4876376-A
优先权日:1983-06-23
标题 :Process for the halogenation, nitration and fluorination of aromatic derivatives
发明人:DESBOIS MICHAEL; DISDIER CAMILLE
权利人:RHONE POULENC SPEC CHIM
摘要:A process for the halogenation (bromination or chlorination)/nitration/fluorination of aromatic derivatives substituted by at least one group containing a halogenoalkyl unit. The aromatic derivative is reacted with a halogen and a nitrating agent in liquid hydrofluoric acid. The products obtained are useful as intermediates for the synthesis of compounds having a plant-protecting or pharmaceutical activity.
专利号:US-4575571-A
优先权日:1983-06-23
标题:Process for the simultaneous halogenation and fluorination of aromatic derivatives
发明人:DESBOIS MICHEL; DISDIER CAMILLE
权利人:RHONE POULENC SPEC CHIM
摘要:A process for the stimulaneous halogenation and fluorination of aromatic derivatives substituted by at least one group containing a halogenoalkyl unit. The aromatic derivative is reacted with the halogen in liquid hydrofluoric acid. The products obtained are useful as intermediates for the synthesis of compounds having a plant-protecting or pharmaceutical activity.
专利号:US-8178559-B2
优先权日:2004-12-30
标 题:Organic compounds
发明人:BREITENSTEIN WERNER; EHARA TAKERU; EHRHARDT CLAUS; GROSCHE PHILIPP; HITOMI YUKO; IWAKI YUKI; KANAZAWA TAKANORI; KONISHI KAZUHIDE; MAIBAUM JUERGEN KLAUS; MASUYA KEIICHI; IWASAKI ATSUKO; OSTERMANN NILS; SUZUKI MASAKI; TOYAO ATSUSHI; YOKOKAWA FUMIAKI
权利人:BREITENSTEIN WERNER; EHARA TAKERU; EHRHARDT CLAUS; GROSCHE PHILIPP; HITOMI YUKO; IWAKI YUKI; KANAZAWA TAKANORI; KONISHI KAZUHIDE; MAIBAUM JUERGEN KLAUS; MASUYA KEIICHI; IWASAKI ATSUKO; OSTERMANN NILS; SUZUKI MASAKI; TOYAO ATSUSHI; YOKOKAWA FUMIAKI; NOVARTIS AG
摘要:3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4substituted piperidine compound, a method for the manufacture of a 3,4-substituted piperidine compound, and novel intermediates and partial steps for their synthesis are disclosed. The 3,4-disubstituted piperidine compounds have the formula (I), wherein the symbols have the meanings defined in the specification.